AstraZeneca to Invest $2.5 Billion in China Amid Probes
www.wsj.com
The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies, at a time when Chinese authorities are probing it.
0 Comentários ·0 Compartilhamentos ·23 Visualizações